Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Intent to Sole Source - Reagents and Consumables required for Systemic Autoimmune Rheumatic Diseases.

Closed
NOI-CC-OLAO-26-006103Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) IIThe Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) II contract focuses on providing research, technology development, and engineering support to advance NASA’s aircraft and spaceflight system missions. This contract covers a broad range of activities including scientific research, engineering design and analysis, advancing technology readiness levels, managing and implementing technology programs, conducting tests and operations, and supporting program and project management efforts. The work aims to adapt and enhance capabilities to meet evolving NASA mission requirements, ensuring continued innovation and technical progress in aeronautics and spaceflight systems. The contract is forecasted to be performed primarily at Moffett Field and falls under the NAICS code 541715, which relates to research and development services. While details about set-aside status are yet to be determined, the contract offers opportunities for various types of organizations to participate. Points of contact for the contract are Mary E. Livingston and Robert E. Watts, who serve as the main liaison and small business specialist respectively. This contract underscores NASA’s commitment to advancing scientific and engineering frontiers through comprehensive support of aeronautics and spaceflight system development.
Ames Research Center

POSTED

in almost 3 years

DEADLINE

N/A

AI Contract Overview

Show more

The National Institutes of Health (NIH), specifically the Office of Purchasing and Contracts acting for the Critical Care Medicine Department, plans to enter into a firm-fixed price contract with 10X Genomics, Inc. for the procurement of reagents and consumables necessary for research or treatment related to Systemic Autoimmune Rheumatic Diseases. This acquisition will be conducted on a sole-source basis under the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, citing that only one responsible vendor is capable of fulfilling the agency’s unique requirements, thus not opening this opportunity to full and open competition. Although this notice is not a request for proposals, interested and capable vendors are invited to submit capability statements for consideration by June 2, 2026, though the decision to compete or proceed with the sole source award remains at the government’s sole discretion. The contract is identified under solicitation number NOI-CC-OLAO-26-006103 and is aimed at acquiring highly specialized materials critical to NIH's work in autoimmune diseases, with performance and administration centered in Bethesda, Maryland. No set-aside designations apply to this acquisition.

General Info

NIH to award sole-source firm-fixed price contract to 10X Genomics for autoimmune disease reagents.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

Justification for Other than Full and Open Competition for NIH Reagents Acquisition

DOCXjustification-and-authorization

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
ContactsNo contacts available
OfficeBethesda, MD, 20892, US
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
Office AddressBethesda, MD, 20892, US
ContactsNo contact information available

Full Description

Show more

This is a Notice of Intent, not a request for proposal.  The National Institute of Health intends to negotiate on an other than full and open competition basis with the following vendor: 10X Genomics, Inc.


Acquisition Description:


The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a firm-fixed priced contract to 10X  Genomics Inc. for the acquisition of reagents and consumables required for Systemic Autoimmune Rheumatic Diseases.


The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006103) by 12:00 PM eastern standard time on 06/02/2026 to: valerie.gregorio@nih.gov.


All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.